ALX Oncology Holdings Inc.ALXONASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
5 yr
Consecutive declineDecelerating
PeriodValue
2025-8.60%
2024-8.39%
2023-1.90%
202224.17%
202157.91%
2020347.00%
201927.37%
20180.00%